Lots of well known peptides can no longer be compounded by pharmacies for human use on account of new FDA regulatory variations. The FDA has moved numerous of these substances to Classification two of its Bulk Drug Substances record, citing protection hazards or insufficient knowledge, making them ineligible for compounding. Screening & Quality